Cargando…
Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus
Preclinical development of and research on potential Middle East respiratory syndrome coronavirus (MERS-CoV) medical countermeasures remain preliminary; advancements are needed before most countermeasures are ready to be tested in human clinical trials. Research priorities include standardization of...
Autores principales: | Uyeki, Timothy M., Erlandson, Karl J., Korch, George, O’Hara, Michael, Wathen, Michael, Hu-Primmer, Jean, Hojvat, Sally, Stemmy, Erik J., Donabedian, Armen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918159/ https://www.ncbi.nlm.nih.gov/pubmed/27191188 http://dx.doi.org/10.3201/eid2207.160022 |
Ejemplares similares
-
Meeting the challenges of medical countermeasure development
por: Maher, Carmen, et al.
Publicado: (2012) -
Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability
por: Kim, Yeon-Sook, et al.
Publicado: (2020) -
Differences in the seasonality of Middle East respiratory syndrome coronavirus and influenza in the Middle East
por: He, Daihai, et al.
Publicado: (2015) -
Bioaerosol Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Referral Center with Critically Ill Coronavirus Disease 2019 (COVID-19) Patients March–May 2020
por: Lane, Morgan A, et al.
Publicado: (2021) -
Dose-response Relation Deduced for Coronaviruses From Coronavirus Disease 2019, Severe Acute Respiratory Syndrome, and Middle East Respiratory Syndrome: Meta-analysis Results and its Application for Infection Risk Assessment of Aerosol Transmission
por: Zhang, Xiaole, et al.
Publicado: (2020)